Nutanix Faces Healthy Demand Ahead of Q4 Results, FY Guidance, UBS Says

Nutanix Faces Healthy Demand Ahead of Q4 Results, FY Guidance, UBS Says

By
Publication Date: 2026-08-25 15:47:00


Real-time Estimate


12:48:17 2026-08-25 pm EDT

5-day change 1st Jan Change

66.70 USD

+0.04% +1.11%